PlainRecalls
FDA Drug Moderate Class II Terminated

CYTARAbine for Injection USP, lyophiled in glass vials, 1 gram per vial, Rx only, Distributed by Bedford Laboratories, Bedford, OH 44146, Manufactured by Ben Venue Labs, Inc., Bedford, OH 44146, NDC 55390-808-01

Reported: August 27, 2014 Initiated: July 31, 2014 #D-1543-2014

Product Description

CYTARAbine for Injection USP, lyophiled in glass vials, 1 gram per vial, Rx only, Distributed by Bedford Laboratories, Bedford, OH 44146, Manufactured by Ben Venue Labs, Inc., Bedford, OH 44146, NDC 55390-808-01

Reason for Recall

Lack of Assurance of Sterility: Crimp defects during visual inspection could affect container closure integrity.

Details

Units Affected
7172 vials
Distribution
Nationwide
Location
Bedford, OH

Frequently Asked Questions

What product was recalled?
CYTARAbine for Injection USP, lyophiled in glass vials, 1 gram per vial, Rx only, Distributed by Bedford Laboratories, Bedford, OH 44146, Manufactured by Ben Venue Labs, Inc., Bedford, OH 44146, NDC 55390-808-01. Recalled by Ben Venue Laboratories Inc. Units affected: 7172 vials.
Why was this product recalled?
Lack of Assurance of Sterility: Crimp defects during visual inspection could affect container closure integrity.
Which agency issued this recall?
This recall was issued by the FDA Drug on August 27, 2014. Severity: Moderate. Recall number: D-1543-2014.